8-K: NexGel Secures $1.8M for Acquisition, Eyes $55M Convertible Note Facility
Capital Raise
NexGel, Inc. has secured $1.797 million in Series A convertible notes to fund a potential acquisition, with an additional $14.869 million contingent on the acquisition's closing and further capital up to $40 million available.
Summary
- NexGel, Inc. entered into a Securities Purchase Agreement with an institutional investor for a 10% original issue discount (OID) convertible note facility totaling up to $56,667,667.
- The initial tranche includes $1,797,381 in Series A Senior Secured Convertible Notes, issued on February 10, 2026, with gross proceeds of $1,797,381.
- The net proceeds from the Series A notes are primarily designated for an Approved Acquisition.
- An additional $14,869,286 in Series B Senior Secured Convertible Notes is mandated if the Approved Acquisition is consummated by April 15, 2026, with these proceeds also allocated to the acquisition.
- Further Series B notes up to $40,000,000 may be issued in subsequent closings, contingent on market conditions and company performance metrics.
- The convertible notes bear interest at 10% per annum, increasing to 18% upon an Event of Default, payable monthly starting May 1, 2026.
- The Series A notes are convertible into common stock at a fixed price of $1.244 per share, subject to adjustment. Alternate conversion prices are available, offering conversion at a discount based on recent trading VWAP, with a floor price of $0.2488 per share.
- The notes are senior secured obligations, backed by a first priority security interest in substantially all of the company's assets.
- Stockholder approval is required for several corporate actions, including redomestication to Nevada, reverse stock splits up to 250-to-1, increasing authorized common stock from 25,000,000 to 250,000,000, and approving the issuance of all securities in compliance with Nasdaq rules.
- Palladium Capital Group, LLC acted as the placement agent, entitled to a 7% cash fee of aggregate gross proceeds upon consummation of the Approved Acquisition, with 25% of this fee convertible into a promissory note, and warrants for 7% of shares sold.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a high-risk, high-cost financing that, while providing immediate capital, places significant burdens on the company through high interest rates, potential for substantial dilution, and numerous performance-based conditions and penalties.
Positives
- Secured immediate funding of $1.797 million for a strategic acquisition.
- Potential for substantial additional capital up to $54.869 million, contingent on the acquisition and market performance, which could fuel significant growth.
- The financing is structured to support a specific Approved Acquisition, indicating a clear strategic use of capital.
Negatives
- The convertible notes carry a high interest rate of 10% per annum, escalating to 18% upon an Event of Default, indicating a high cost of capital.
- Conversion terms, including alternate conversion prices based on discounted VWAP and a low floor price of $0.2488, expose existing shareholders to significant potential dilution.
- The requirement for multiple stockholder approvals for corporate actions (redomestication, reverse stock splits, authorized share increase) introduces execution risk and potential for delays.
- A 2% penalty of the original principal amount is incurred for each 30-day period of delay in filing or achieving effectiveness of the registration statement for Series B shares.
- The company is restricted from using net proceeds for certain purposes, including satisfaction of other indebtedness (except Series A notes), redemption/repurchase of securities (except as permitted), or settlement of outstanding litigation.
Risks
- The potential acquisition is subject to the completion of due diligence by both NexGel and the investor, and the funds will be returned if the transaction is not consummated.
- The maturity date of the convertible notes is subject to adjustment if certain conditions with respect to the Approved Acquisition are not met.
- Failure to file the required registration statement for Series B Conversion Shares by the Filing Deadline (30 days after initial Series B issuance) or to achieve effectiveness by the Effectiveness Deadline (60/120 days) will result in a 2% penalty every 30 days.
- The company faces risks of delisting or suspension from Nasdaq if it fails to meet minimum listing maintenance requirements (Equity Conditions Failure), which can be triggered by low trading volume (< $100,000 daily) or low stock price (VWAP < $0.75).
- Maintaining a minimum liquidity of $500,000 in Available Cash is a covenant, with a 5-day cure period for any shortfall.
- The company is restricted from engaging in Variable Rate Transactions (except Permitted VRTs) and from issuing other securities that would cause a breach or default under the notes.
- Investors are prohibited from maintaining a Net Short Position in the company's stock while holding notes.
- General risks and uncertainties associated with forward-looking statements, as detailed in the company's Annual Report on Form 10-K, could materially affect actual results.
Future Outlook
The company's immediate future outlook is centered on the successful completion of due diligence and consummation of the Approved Acquisition. It anticipates providing shareholders with further information on the acquisition during the first quarter of 2026. The ability to secure additional Series B funding is contingent on the acquisition's success and meeting specific market performance and corporate governance conditions.
Management Comments
- Adam Levy, CEO of NEXGEL, stated: 'After successfully closing and integrating several acquisitions over the last several years, we have continued to evaluate other potential accretive transactions.'
- Adam Levy also noted: 'We have identified assets to acquire with an up-front commitment from an investor in the amount of $1.797 million and a potential additional investment of $14.869 million relating to the acquisition, pending the completion of full due diligence by both parties and subject to other conditions.'
- Adam Levy further commented: 'We expect to provide shareholders with further information on the acquisition during the first quarter of 2026.'
Industry Context
StockSavvy.ai notes that this financing structure, involving senior secured convertible notes with significant dilution potential and performance-based tranches, is common for smaller public companies seeking capital for strategic growth, particularly acquisitions, in competitive markets. The reliance on shareholder approval for key corporate actions and further funding tranches indicates a need for strong investor confidence and alignment, often seen in companies with limited access to traditional, less dilutive financing options. The terms reflect the current market's risk assessment of NexGel's growth prospects and financial stability.
Comparison to Industry Standards
- The 10% interest rate (18% default) on senior secured convertible notes is relatively high compared to typical corporate debt, reflecting a higher perceived risk for NexGel, Inc. in the current market environment. For instance, established companies with strong credit ratings might secure similar debt at 4-7% interest.
- The conversion price of $1.244 per share and a floor price of $0.2488, coupled with VWAP-based alternate conversion options, are aggressive anti-dilution protections for the investor. This is more dilutive than standard convertible notes which often have conversion premiums above the current market price, indicating the investor's strong negotiating position due to the company's capital needs.
- The 7% placement agent fee and warrants for 7% of shares sold, contingent on the Approved Acquisition, are on the higher end for capital raises, especially when compared to larger, more stable companies that typically pay 2-5% in fees for similar transactions. This further underscores the cost of capital for NexGel.
- The requirement for multiple shareholder approvals for corporate actions like reverse stock splits and increasing authorized shares is a significant governance hurdle not always present in more robust financing deals, suggesting the company is addressing potential listing compliance issues or preparing for substantial future equity issuance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Proposed Redomestication | Stockholder approval is required for the redomestication of the Company to the State of Nevada. | NA | Could alter the legal framework governing the company and its shareholders, potentially affecting corporate flexibility or shareholder rights depending on Nevada law. |
| Proposed Reverse Stock Split | Stockholder approval is required for one or more reserve stock splits over the next twelve months, up to an aggregate ratio of 250 shares-to-1 share. | NA | A reverse stock split typically aims to increase share price to meet listing requirements but can be perceived negatively by the market and may not fundamentally improve company value. It also reduces the number of outstanding shares, making subsequent dilution from convertible notes more impactful on a per-share basis. |
| Proposed Increase in Authorized Shares | Stockholder approval is required to increase the authorized shares of Common Stock from 25,000,000 to 250,000,000. | NA | A significant increase in authorized shares provides the company with flexibility for future capital raises, acquisitions, or stock-based compensation, but also signals a high potential for future equity dilution for existing shareholders. |
| Issuance Compliance Approval | Stockholder approval is required for the issuance of all of the Securities in compliance with the rules and regulations of Nasdaq Capital Markets. | NA | Ensures compliance with exchange rules, which is critical for maintaining listing, but requires shareholder endorsement of the dilutive financing terms. |
Legal Proceedings
- The company is prohibited from using the net proceeds from the offering for the settlement of any outstanding litigation.
Stakeholder Impact
- **Shareholders**: Existing shareholders face significant potential for dilution due to the convertible nature of the notes, especially with discounted conversion prices and potential future stock splits. They are also required to approve major corporate governance changes, which could further impact their ownership percentage and voting power.
- **Noteholders (Investor)**: The institutional investor benefits from a senior secured position, high interest rates (10%, 18% on default), and favorable conversion terms designed to protect against downside and maximize equity upside. The structure provides strong downside protection and significant potential returns.
- **Employees/Management**: The financing provides capital for a strategic acquisition, potentially leading to growth and expansion. However, it also places pressure on management to successfully integrate the acquisition and meet financial covenants and performance targets to avoid penalties and ensure future funding tranches.
Next Steps
- Complete due diligence for the Approved Acquisition.
- Consummate the Approved Acquisition by April 15, 2026.
- Obtain stockholder approval for redomestication to Nevada, reverse stock splits, increase in authorized shares, and issuance of all securities in compliance with Nasdaq rules.
- File a registration statement for Series B Conversion Shares within 30 days after the initial issuance of Series B Notes.
- Cause the Series B registration statement to be declared effective within 60 days (or 120 days for full SEC review) after the initial issuance of Series B Notes.
- Maintain minimum liquidity of $500,000 at the end of each fiscal quarter, commencing on the First Additional Mandatory Closing Date (or earlier if $14,849,058 of Notes are issued).
- Publicly disclose further information on the acquisition during the first quarter of 2026.
Key Dates
| Date | Description |
|---|---|
| 2023-06-07 | Company's Registration Statement on Form S-3 (File No. 333-264282) declared effective by the SEC. |
| 2026-02-09 | Date of Securities Purchase Agreement with institutional investor. |
| 2026-02-10 | Issuance Date of Series A Senior Secured Convertible Notes; Company received gross proceeds of $1,797,381. Also, Security and Pledge Agreement and Registration Rights Agreement entered into. |
| 2026-02-28 | Deadline for the Company to enter into a definitive agreement for the Approved Acquisition. |
| 2026-04-15 | Deadline for the Approved Acquisition to occur; triggers mandatory purchase of $14,869,286 in Series B Convertible Notes. |
| 2026-05-01 | First Interest Date for convertible notes, with interest payable monthly thereafter. |
| NA | Filing Deadline for initial Registration Statement for Series B Conversion Shares: 30 calendar days after the Initial Closing Date of Series B Notes. |
| NA | Effectiveness Deadline for initial Registration Statement for Series B Conversion Shares: 60 calendar days (or 120 days in case of full SEC review) after the Initial Closing Date of Series B Notes. |
| NA | Stockholder Meeting Deadline: Not later than 60 days following the Initial Closing Date for stockholder approval of corporate actions. |
| NA | Maturity Date of Convertible Notes: Two-year anniversary of the applicable issuance date, subject to adjustment if Approved Acquisition conditions are not met. |
Recommendation
strong sellThe financing terms are highly unfavorable for existing shareholders, indicating significant financial distress or a very high-risk profile for the company. The 10% interest rate (18% upon default) on senior secured convertible notes, coupled with deeply dilutive conversion features (Alternate Conversion Price based on discounted VWAP, low Floor Price of $0.2488), suggests that the company is raising capital at a very high cost and is willing to sacrifice substantial equity to do so. The requirement for multiple shareholder approvals for corporate actions like reverse stock splits and increasing authorized shares further signals potential future dilution and a need to maintain Nasdaq listing compliance, which can be a red flag. The 2% penalty for registration statement delays adds to the financial burden. While the capital is intended for an acquisition, the terms of this financing heavily favor the investor at the expense of current equity holders, making it a strong sell for existing shareholders.
Keywords
NexGel, NXGL, Convertible Notes, Senior Secured Debt, Acquisition Financing, Equity Dilution, Nasdaq, SEC Filing, Capital Raise, Private Placement, Registered Direct, Corporate Governance, Risk Factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.